Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.82−0.02 (-1.09%)
Close on Nov 17, 2026Market cap $565.71MP/E –Yield 0.00%
Pacific Biosciences of California pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Pacific Biosciences of California's pe ratio was 195.2× on Apr 30, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 195.2× | – |
See a number that looks wrong?